Cann Group Limited
OTC: CNGGF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jennifer Lee Pilcher
- Employees
- 98
- Headquarters
- Port Melbourne, Australia
- IPO year
- 2021
- Market cap
- $2.4M
- Website
- https://www.canngrouplimited.com
Loading CNGGF…
Loading profile data…Frequently asked questions about CNGGF
What does Cann Group Limited (CNGGF) do?
Cann Group Limited specializes in the end-to-end process of bringing medicinal cannabis to market. Its activities span from genetic development and cultivation to product manufacturing, clinical trials, and ultimately, the supply of therapeutic cannabis for both Australian consumption and international export. The company holds specific licenses...
Where does CNGGF trade?
Cann Group Limited (CNGGF) trades on the Other OTC.
What sector is CNGGF in?
Cann Group Limited (CNGGF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Cann Group Limited?
Jennifer Lee Pilcher is the chief executive officer of Cann Group Limited (CNGGF).
Where is Cann Group Limited headquartered?
Cann Group Limited is headquartered in Australia.
Does CNGGF pay a dividend?
Cann Group Limited (CNGGF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CNGGF go public?
Cann Group Limited (CNGGF) completed its initial public offering in 2021.